Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Pegah Karimi Elizee"'
Publikováno v:
International Journal of Preventive Medicine, Vol 4, Iss 8, Pp 863-865 (2013)
Externí odkaz:
https://doaj.org/article/1a52f182e4d34e858af18bcaebf3b2be
Autor:
Heidar Sharafi, Farah Bokharaei-Salim, Shima Salimi, Maryam Keshvari, Seyyed Mohammad Miri, Pegah Karimi Elizee, Hosein Keyvani, Seyed Moayed Alavian, Bita Behnava
Publikováno v:
Iranian Red Crescent Medical Journal. 19
Background: Sustained virologic response (SVR) to pegylated-interferon (PegIFN) and ribavirin (RBV) in hepatitis C virus (HCV)-infected patients could be predicted by detection of serum HCV RNA whereas detection of HCV RNA in other reservoirs such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c91bed4dc3fc9f0108eaa2735c3a3326
https://doi.org/10.5812/ircmj.46578
https://doi.org/10.5812/ircmj.46578
Autor:
Seyyed Mohammad Miri, Pegah Karimi Elizee, Bita Behnava, Seyed Moayed Alavian, Ali Pouryasin, Shima Salimi, Heidar Sharafi, Maryam Keshvari
Publikováno v:
Hepatitis Monthly. 17
Background and Aims: The presence of the hepatitis C virus (HCV) in cells of extrahepatic organs like peripheral blood mononuclear cells (PBMCs) have important implications for transmission, disease progression, and effective treatment of HCV-infecte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5a4d6da04a3ee887d16cecf84042fd6
https://doi.org/10.5812/hepatmon.46539
https://doi.org/10.5812/hepatmon.46539
Publikováno v:
Thrita.
Context: Peripheral blood mononuclear cells (PBMC), as the main extrahepatic reservoir of HCV infection, play an important role in HCV progression. Numerous host microRNAs (miRNAs) are probably involved in HCV entry, the formation of viral infection,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c52fea6be9f2e091110617f322ca59e1
https://doi.org/10.5812/thrita.46666
https://doi.org/10.5812/thrita.46666
Autor:
Leila Mehrnoush, Bita Behnava, Danesh Kadjbaf, Maryam Keshvari, Pegah Karimi Elizee, Ali Pouryasin, Shima Salimi, Seyed Moayed Alavian, Heidar Sharafi
Publikováno v:
Hepatitis Monthly
Background: Molecular studies have demonstrated that the hepatitis C virus (HCV) genotype and host genetics play predictive roles in the management of patients infected with HCV. Objectives: This study aimed to investigate the HCV genotype, core amin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f873b7322cdc2b4ba21532920fad5719
https://doi.org/10.5812/hepatmon.37011
https://doi.org/10.5812/hepatmon.37011
Autor:
Ahmad Gharehbaghian, Seyed Moayed Alavian, Sedigheh Amini Kafi-Abad, Bashir Hajibeigy, Farhad Zamani, Seyyed Mohammad Miri, Pegah Karimi Elizee, Seyed Vahid Tabatabaei, Bita Behnava, Maryam Keshvari, Kamran Bagheri Lankarani
Publikováno v:
Hepatitis Monthly
Background Treatment guidelines contraindicate ribavirin for treatment of hepatitis C virus (HCV) infection in thalassemia major patients. Nevertheless, the current evidence suggests that ribavirin might be tolerated by these patients. Objectives Des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78d091cbf66c5741119b02553d582097
https://doi.org/10.5812/hepatmon.6592
https://doi.org/10.5812/hepatmon.6592
Autor:
Pegah Karimi Elizee, Kamran Bagheri Lankarani, Seyed Vahid Tabatabaei, Bita Behnava, Maryam Keshvari, Seyyed Mohammad Miri, Seyed Moayed Alavian
Publikováno v:
Liver International. 30:1173-1180
BACKGROUND/AIMS Chronic hepatitis C virus infection (HCV) is a major comorbidity in patients with haemophilia. Peginterferon alpha and ribavirin is current standard anti-HCV therapy but there is little information about safety and efficacy of peginte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fb5d189d7bd18ca97892ec96bfd0343
https://doi.org/10.1111/j.1478-3231.2010.02296.x
https://doi.org/10.1111/j.1478-3231.2010.02296.x
Autor:
Seyyed Mohammad Miri, Maryam Keshvari, Bita Behnava, Seyed Moayed Alavian, Kamran Bagheri Lankarani, S. V. Tabatabaei, Pegah Karimi Elizee
Publikováno v:
Transfusion. 49:2195-2199
BACKGROUND: Hepatitis C virus (HCV) infection is the most common transfusion-transmitted disease in multiply transfused patients worldwide. In this study, the aim was to investigate distribution of HCV genotypes in Iranian patients with thalassemia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96cb1999b85e1c2b8ee307febda31aa0
https://doi.org/10.1111/j.1537-2995.2009.02252.x
https://doi.org/10.1111/j.1537-2995.2009.02252.x
Autor:
Seyed Moayed Alavian, Shima Salimi, Heidar Sharafi, Ali Pouryasin, Maryam Keshvari, Mehran Ghazimoghaddam, Bita Behnava, Pegah Karimi Elizee, Leila Mehrnoush
Publikováno v:
Hepatitis Monthly
Background: Hepatitis C Virus (HCV) is the major cause of liver failure in thalassemic patients. In these patients, iron overload and their comorbidities make difficulties during Pegylated-Interferon (PEG-IFN) and Ribavirin (RBV) therapy. Objectives:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4440f328a0ec63fbdccb042f292f4417
https://doi.org/10.5812/hepatmon.32703
https://doi.org/10.5812/hepatmon.32703
Autor:
Seyed Moayed Alavian, Pegah Karimi Elizee, Heidar Sharafi, Bita Behnava, Leila Mehrnoush, Maryam Keshvari, Saleh Sandoughdaran, Shima Salimi
Publikováno v:
Hepatitis Monthly
Background: Most thalassemic patients with chronic hepatitis C virus (HCV) infection do not respond to therapy with pegylated interferon (Peg-IFN) plus ribavirin (RBV) due to hepatic siderosis and RBV dose reduction caused by RBV-induced anemia. Obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::883b33df53f8331b4529ccb52fe8ba97
https://doi.org/10.5812/hepatmon.23564
https://doi.org/10.5812/hepatmon.23564